Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Kinesio Taping in Women With Primary Dysmenorrhea

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03915145
Recruitment Status : Recruiting
First Posted : April 16, 2019
Last Update Posted : April 16, 2019
Sponsor:
Information provided by (Responsible Party):
Seyda TOPRAK CELENAY, Ataturk Training and Research Hospital

Brief Summary:
The aim of our study was to investigate the effects of kinesio taping in women with primary dysmenorrhea.

Condition or disease Intervention/treatment Phase
Primary Dysmenorrhea Other: Kinesio tape application Other: Sham Kinesio tape application Other: No intervention Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Assistant Professor, Physioterapist, PhD
Actual Study Start Date : March 10, 2019
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : September 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Kinesio tape group
Kinesio tape application has been applied
Other: Kinesio tape application
Kinesio tape application will be performed.Taping is carried out from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

Sham Comparator: Sham group
Sham kinesio tape application has been applied
Other: Sham Kinesio tape application
Sham kinesio tape application will be performed. Sham taping is carried out from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

Control group
No intervention has been applied
Other: No intervention
The natural process will be followed from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins




Primary Outcome Measures :
  1. The severity of menstrual pain assessed with Visual Analog Scale [ Time Frame: An average of 2 weeks ]
    A 10-cm Visual Analog Scale anchored from zero (no pain at all) to 10 (the worst pain I have ever felt) was used to determine the severity of each subject's menstrual pain.


Secondary Outcome Measures :
  1. The complaints related to menstruation will be evaluated by a form prepared by the researchers [ Time Frame: An average of 2 weeks ]
    The form assessing the complaints related to menstruation will be evaluated existing complaints affect the patient and expressed as, no, little, mederate, very.

  2. The level of anxiety will be evaluated with The Spielberger State Trait Anxiety Inventory [ Time Frame: An average of 2 weeks ]
    The Spielberger State Trait Anxiety Inventory is a 40-item self-report inventory designed to measure both state anxiety section (current feelings of apprehension, worry, etc.) and trait anxiety section (continuous feelings of apprehension, worry, etc.). Each section is scored on four levels of anxiety intensity from 1="not at all" to 4="very much" and with a sum score between 20 and 80. A higher total score indicates more severe anxiety level.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 to 35 years of age,
  • having Primary Dysmenorrhea
  • being volunteer women

Exclusion Criteria:

  • having give birth,
  • having a serious psychiatric disorder
  • having used oral contraceptive or depression drug in the last 6 month
  • having secondary dysmenorrhea
  • having irregular menstrual cycle
  • having allergy to taping

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03915145


Contacts
Layout table for location contacts
Contact: Seyda TOPRAK CELENAY +90-534-041-3986 sydtoprak@hotmail.com
Contact: Basak KAVALCI +90-552-227-02-94 kavalcibasak@gmail.com

Locations
Layout table for location information
Turkey
Ankara Yildirim Beyazit University Recruiting
Ankara, Turkey
Contact: Aysenur Karakus         
Sponsors and Collaborators
Ataturk Training and Research Hospital
Investigators
Layout table for investigator information
Principal Investigator: Seyda TOPRAK CELENAY Ankara Yildirim Beyazıt University
Study Chair: Basak Kavalci Gumushane University
Study Chair: Aysenur Karakus Ankara Yildirim Beyazıt University
Layout table for additonal information
Responsible Party: Seyda TOPRAK CELENAY, Assistant Professor, Ataturk Training and Research Hospital
ClinicalTrials.gov Identifier: NCT03915145    
Other Study ID Numbers: 442-15
First Posted: April 16, 2019    Key Record Dates
Last Update Posted: April 16, 2019
Last Verified: April 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Dysmenorrhea
Menstruation Disturbances
Pathologic Processes
Pelvic Pain
Pain
Neurologic Manifestations